CVR number 39919575
Industry 468900

LabDidakt ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  11.6% 7.6% 7.1% 8.4% 18.7%  
Credit score (0-100)  21 31 33 28 7  
Credit rating  BB BB BBB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  175 279 219 233 24.5  
EBITDA  175 279 219 233 -41.9  
EBIT  175 279 219 233 -41.9  
Pre-tax profit (PTP)  170.2 273.0 220.6 227.5 -57.7  
Net earnings  131.1 210.5 170.9 173.9 -42.2  
Pre-tax profit without non-rec. items  170 273 221 228 -57.7  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  209 419 590 764 2,080  
Interest-bearing liabilities  318 199 240 49.3 0.0  
Balance sheet total (assets)  620 747 967 993 2,172  
Net Debt  264 158 195 19.0 -321  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  175 279 219 233 24.5  
Gross profit growth  343.1% 59.8% -21.4% 6.2% -89.5%  
Employees  0 0 0 0 1  
Employee growth %  -100.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  620 747 967 993 2,172  
Balance sheet change%  66.7% 20.6% 29.4% 2.7% 118.6%  
Added value  174.7 278.8 219.4 232.9 -41.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 -1.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 99.9% 100.0% 100.0% -170.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  35.3% 40.8% 25.8% 23.8% -3.2%  
ROI %  40.6% 48.7% 30.5% 28.4% -3.5%  
ROE %  91.6% 67.1% 33.9% 25.7% -3.0%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  33.7% 56.1% 61.0% 76.9% 95.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  150.9% 56.6% 88.7% 8.2% 764.8%  
Gearing %  152.4% 47.6% 40.6% 6.5% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  1.7% 2.3% 0.1% 4.1% 27.5%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.3 0.5 0.4 0.5 6.5  
Current Ratio  1.5 2.3 2.5 4.3 23.6  
Cash and cash equivalent  54.4 41.5 45.2 30.3 320.8  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  202.6 413.1 584.0 763.9 2,079.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 -42  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 -42  
EBIT / employee  0 0 0 0 -42  
Net earnings / employee  0 0 0 0 -42